In vitro suppression of parathyroid hormone secretion by 22-oxa- calcitriol in human parathyroid hyperplasia due to uraemia

Nephrology

Volumn 4, Issue 3, 1998, Pages 177-182

  Sato, Keisuke ^a   Tominaga, Yoshihiro ^a   Ichikawa, Fumihiko ^b   Uchida, Kazuharu ^a   Takezawa, Jun Ichi ^c   Tsuchiya, Takeshi ^d   Kubodera, Noboru ^b   Takagi, Hiroshi ^e  

^a NAGOYA DAINI RED CROSS HOSPITAL   (Japan)

^b CHUGAI PHARMACEUTICAL CO LTD   (Japan)

^c YAMASA CORPORATION   (Japan)

^d ISHINOMAKI SENSHU UNIVERSITY   (Japan)

^e NAGOYA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

22 oxa calcitriol; Parathyroid hormone; Parathyroid hyperplasia; Renal hyperparathyroidism; Uraemia

Indexed keywords

22 OXACALCITRIOL; CALCITRIOL; CALCITRIOL RECEPTOR; PARATHYROID HORMONE;

ADULT; AGED; ANIMAL TISSUE; ARTICLE; CATTLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; EXTRACELLULAR CALCIUM; FEMALE; HUMAN; HUMAN TISSUE; HYPERPARATHYROIDISM; MALE; NONHUMAN; PARATHYROID HORMONE RELEASE; PARATHYROID HYPERPLASIA; PRIORITY JOURNAL; UREMIA;

EID: 0031904250     PISSN: 13205358     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1440-1797.1998.d01-28.x     Document Type: Article

References (31)

1. 3 of transcription of the parathyroid hormone gene. Endocrinol. 1986; 86: 2864-6.
2. 3 inhibits hormone secretion and proliferation but not functional differentiation of cultured bovine parathyroid cells. Calcif. Tiss. Int. 1988; 88: 213-8.
3. Slatopolsky E, Weerts EC, Thielan J, Horst R, Harter H, Martin KJ. Marked suppression of secondary hyperparathyroidism by intravenous administration of 1,25-dihydroxycholecalciferol in uremic patients. J. Clin. Invest. 1984; 84: 2136-43.
4. Andress DL, Norris KC, Coburn JW, Slatopolsky EA, Sherrard DJ. Intravenous calcitriol in the treatment of refractory osteitis fibrosa of chronic renal failure. N. Engl. J. Med. 1989; 89: 274-9.
5. 3 and low dialysate calcium. Kidney Int. 1993; 41: S121-4.
6. 3 in the parathyroid glands of patients with renal failure. N. Engl. J. Med. 1987; 87: 1573-7.
7. 3 receptor density is associated with a more severe form of parathyroid hyperplasia in chronic uremic patients. J. Clin. Invest. 1993; 93: 1436-43.
8. Tominaga Y, Tanaka Y, Sato K, Nagasaka T, Takagi H. Histopathology, pathophysiology, and indications for surgical treatment of renal hyperparathyroidism. Seminars Surg. Oncol. 1997; 97: 78-86.
9. Tominaga Y, Kohara S, Namii Y et al. Clonal analysis of nodular parathyroid hyperplasia in renal hyperparathyroidism. World J. Surg. 1996; 96: 744-52.
10. Milliner DS, Zinsmeister AR, Lieberman E, Landing B. Soft tissue calcification in pediatric patients with end-stage renal disease. Kidney Int. 1990; 90: 931-6.
11. Tominaga Y, Numano M, Uchida K et al. Parathyroidectomy for patients with renal hyperparathyroidism refractory to calcitriol pulse therapy. J. Bone Miner. Met. 1994; 94: S99-104.
12. Brown AJ, Ritter CR, Finch JL et al. The noncalcemic analogue of vitamin D, 22-oxacalcitriol, suppressed parathyroid hormone synthesis and secretion. J. Clin. Invest. 1989; 89: 728-32.
13. Fukagawa M, Kaname S, Igarashi T, Ogata E, Kurokawa K. Regulation of parathyroid hormone synthesis in chronic renal failure in rats. Kidney Int. 1991; 91: 874-81.
14. Tominaga Y, Numano M, Tanaka Y, Uchida K, Takagi H. Surgical treatment of renal hyperparathyroidism. Seminars Surg. Oncol. 1997; 97: 87-96.
15. Nygren P, Larsson R, Gylfe E et al. Development of abnormal parathyroid cell function during monolayer culture and its relation to cellular hypertrophy and proliferation. Acta Pathol. Microbiol. Immunol. Scand. 1987; 87: 207-14.
16. Brown EM, Hurwitz S, Aurback GP. Preparation of viable bovine parathyroid cells. Endocrinol. 1976; 76: 1582-8.
17. Morrissey J, Cohn DV. The effect of calcium and magnesium on the secretion of parathormone and parathyroid secretary protein by isolated porcine parathyroid cells. Endocrinol. 1978; 78: 2081-90.
18. 3 suppresses PTH secretion from bovine parathyroid cells in tissue culture. Endocrinol. 1985; 85: 2114-9.
19. Silver J, Neveh-Many T, Mayer H, Schmeizer HJ, Popovtzer MM. Regulation by vitamin D metabolites of parathyroid hormone gene transcription in vivo in the rat. J. Clin. Invest. 1986; 86: 1296-301.
20. 3. Proc. Natl. Acad. Sci. USA 1992; 89: 8097-101.
21. Silver J, Russell J, Sherwood LM. Regulation by vitamin D metabolites of messenger RNA for pre-proparathyroid hormone in isolated bovine parathyroid cells. Proc. Natl. Acad. Sci. USA 1985; 85: 4270-3.
22. 3 of transcription of the parathyroid hormone gene. Endocrinol. 1986; 86: 2864-6.
23. Dusso AS, Negrea L, Gunawardhana S et al. On the mechanisms for the selective action of vitamin D analogs. Endocrinol. 1991; 91: 1687-92.
24. 3, is a potent modulator of in vivo immunoregulating activity without inducing hypercalcemia in mice. Endocrinol. 1989; 89: 2645-7.
25. Kurokawa K, Akizawa T, Suzuki M, Akiba T, Ogata E, Slatopolsky E. Effect of 22-oxacalcitriol. on hyperparathyroidism of dialysis patients: Results of a preliminary study. Nephrol. Dial. Transplant 1996; 11 (Suppl. 3): 121-4.
26. Tominaga Y, Tanaka Y, Sato K et al. Recurrent renal hyperparathyroidism and DNA analysis of autografted parathyroid tissue. World. Surg. 1992; 92: 595-603.
27. Tominaga Y, Sato K, Tanaka Y, Numano M, Uchida K, Takagi H. Histopathology and pathophysiology of secondary hyperparathyroidism due to chronic renal failure. J. Clin. Nephrol. 1995; 95: S42-7.
28. Okazaki T, Ando K, Igarashi T, Ogata E, Fujita T. The conserved mechanism of negative gene regulation by extracellular calcium-parathyroid hormone gene versus atrial natriuretic polypeptide gene. J. Clin. Invest. 1992; 92: 1268-73.
29. Chertow BS, Baylink JE, Wegedal JE, Su MHH, Norman AW. Decrease in serum immunoreactive parathyroid hormone in rats and in parathyroid hormone secretion in vitro by 1,25-dihydroxycholecalciferol. J. Clin. Invest. 1975; 75: 668-78.
30. Gogusev J, Duchambon P, Hory B et al. Depressed expression of calcium receptor in parathyroid gland tissue of patients with hyperparathyroidism. Kidney Int. 1997; 97: 328-36.
31. Brown AJ, Zhong M, Finch J et al. Rat calcium-sensing receptor is regulated by vitamin D but not by calcium. Am. J. Physiol. 1996; 96: F454-60.